Ovarian Cancer Vaccine Clinical Trial Begins At Cancer Treatment Centers Of America
Cancer Treatment Centers of America (CTCA), a leading provider of innovative cancer care for patients living with complex and advanced-stage disease, has begun accepting patients for an ovarian cancer vaccine clinical trial. The Phase I/II study, recently reviewed and cleared by the U.S.
More: continued here
Filed under: Women's Health / OBGYN on June 1st, 2008